Intellia Therapeutics Inc (NTLA)
Operating Income Growth
17.29%
TTM · Period ending:
NTLA Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported17.29%period ending
Latest reported17.29%period ending
NTLA TTM Operating Income YoY % (-149.69% → 17.29%)
Year-over-year change
High-resolution chart · PNG
NTLA operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 17.2925% | |
| 22.2435% | |
| 17.4583% | |
| 10.969% | |
| 2.2947% | |
| -4.5872% | |
| -3.6818% | |
| -10.7566% | |
| -13.9454% | |
| -21.4757% | |
| -12.4687% | |
| -13.3011% | |
| -16.4459% | |
| -16.4643% | |
| -71.0525% | |
| -86.4354% | |
| -112.4065% | |
| -143.8457% | |
| -96.1079% | |
| -85.4173% | |
| -53.4424% | |
| -29.7153% | |
| -28.4061% | |
| -27.3384% | |
| -26.0805% | |
| -25.3206% | |
| -17.0551% | |
| -2.6403% | |
| -10.9669% | |
| -16.7162% | |
| -30.6448% | |
| -70.3837% | |
| -82.4088% | |
| -105.7559% | |
| -116.2847% | |
| -107.4773% | |
| -111.6797% | |
| -103.1574% | |
| -139.8315% | |
| -121.5908% | |
| -149.6883% |